360 related articles for article (PubMed ID: 18174154)
1. Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation.
Koida N; Ozaki T; Yamamoto H; Ono S; Koda T; Ando K; Okoshi R; Kamijo T; Omura K; Nakagawara A
J Biol Chem; 2008 Mar; 283(13):8555-63. PubMed ID: 18174154
[TBL] [Abstract][Full Text] [Related]
2. Plk3 inhibits pro-apoptotic activity of p73 through physical interaction and phosphorylation.
Sang M; Ando K; Okoshi R; Koida N; Li Y; Zhu Y; Shimozato O; Geng C; Shan B; Nakagawara A; Ozaki T
Genes Cells; 2009 Jul; 14(7):775-88. PubMed ID: 19490146
[TBL] [Abstract][Full Text] [Related]
3. Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1).
Kreis NN; Sommer K; Sanhaji M; Krämer A; Matthess Y; Kaufmann M; Strebhardt K; Yuan J
Cell Cycle; 2009 Feb; 8(3):460-72. PubMed ID: 19177004
[TBL] [Abstract][Full Text] [Related]
4. p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1.
Soond SM; Barry SP; Melino G; Knight RA; Latchman DS; Stephanou A
Cell Cycle; 2008 May; 7(9):1214-23. PubMed ID: 18418051
[TBL] [Abstract][Full Text] [Related]
5. Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation.
Yim H; Erikson RL
Mol Cell Biol; 2009 May; 29(10):2609-21. PubMed ID: 19289504
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation.
Ando K; Ozaki T; Yamamoto H; Furuya K; Hosoda M; Hayashi S; Fukuzawa M; Nakagawara A
J Biol Chem; 2004 Jun; 279(24):25549-61. PubMed ID: 15024021
[TBL] [Abstract][Full Text] [Related]
7. Regulation of p73 by Hck through kinase-dependent and independent mechanisms.
Paliwal P; Radha V; Swarup G
BMC Mol Biol; 2007 May; 8():45. PubMed ID: 17535448
[TBL] [Abstract][Full Text] [Related]
8. Plk1 regulates liver tumor cell death by phosphorylation of TAp63.
Komatsu S; Takenobu H; Ozaki T; Ando K; Koida N; Suenaga Y; Ichikawa T; Hishiki T; Chiba T; Iwama A; Yoshida H; Ohnuma N; Nakagawara A; Kamijo T
Oncogene; 2009 Oct; 28(41):3631-41. PubMed ID: 19668228
[TBL] [Abstract][Full Text] [Related]
9. Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function.
Hanamoto T; Ozaki T; Furuya K; Hosoda M; Hayashi S; Nakanishi M; Yamamoto H; Kikuchi H; Todo S; Nakagawara A
J Biol Chem; 2005 Apr; 280(17):16665-75. PubMed ID: 15723830
[TBL] [Abstract][Full Text] [Related]
10. Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells.
Tyagi S; Bhui K; Singh R; Singh M; Raisuddin S; Shukla Y
Biochem Pharmacol; 2010 Nov; 80(9):1326-34. PubMed ID: 20655883
[TBL] [Abstract][Full Text] [Related]
11. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
Lau LM; Nugent JK; Zhao X; Irwin MS
Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
[TBL] [Abstract][Full Text] [Related]
12. Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage.
Lin YC; Chen YN; Lin KF; Wang FF; Chou TY; Chen MY
Cell Death Dis; 2014 Jan; 5(1):e987. PubMed ID: 24407240
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells.
Million K; Horvilleur E; Goldschneider D; Agina M; Raguénez G; Tournier F; Bénard J; Douc-Rasy S
Int J Oncol; 2006 Jul; 29(1):147-54. PubMed ID: 16773194
[TBL] [Abstract][Full Text] [Related]
14. Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy.
Studach L; Wang WH; Weber G; Tang J; Hullinger RL; Malbrue R; Liu X; Andrisani O
J Biol Chem; 2010 Sep; 285(39):30282-93. PubMed ID: 20624918
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptotic genes by a p73-phosphatase and tensin homolog (p73-PTEN) protein complex in response to genotoxic stress.
Lehman JA; Waning DL; Batuello CN; Cipriano R; Kadakia MP; Mayo LD
J Biol Chem; 2011 Oct; 286(42):36631-40. PubMed ID: 21873427
[TBL] [Abstract][Full Text] [Related]
16. Regulation of I(kappa)B kinase complex by phosphorylation of (gamma)-binding domain of I(kappa)B kinase (beta) by Polo-like kinase 1.
Higashimoto T; Chan N; Lee YK; Zandi E
J Biol Chem; 2008 Dec; 283(51):35354-67. PubMed ID: 18957422
[TBL] [Abstract][Full Text] [Related]
17. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
18. p53-dependent repression of polo-like kinase-1 (PLK1).
McKenzie L; King S; Marcar L; Nicol S; Dias SS; Schumm K; Robertson P; Bourdon JC; Perkins N; Fuller-Pace F; Meek DW
Cell Cycle; 2010 Oct; 9(20):4200-12. PubMed ID: 20962589
[TBL] [Abstract][Full Text] [Related]
19. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria.
John K; Alla V; Meier C; Pützer BM
Cell Death Differ; 2011 May; 18(5):874-86. PubMed ID: 21127500
[TBL] [Abstract][Full Text] [Related]
20. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
Ray RM; Bhattacharya S; Johnson LR
Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
